| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/09/2013 | US8414918 Stable imatinib compositions |
| 04/09/2013 | US8414917 Chewable capsule and production method thereof |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414915 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 04/09/2013 | US8414914 Compositions for mucosal delivery of agents |
| 04/09/2013 | US8414912 Contact lens drug delivery device |
| 04/09/2013 | US8414905 Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect |
| 04/09/2013 | US8414904 Ophthalmic oil-in-water emulsions containing prostaglandins |
| 04/09/2013 | US8414879 Superporous hydrogel with cells encapsulated therein and method for producing the same |
| 04/09/2013 | US8414873 Blood vessel stent of amidoglucosan polysaccharide loaded with CD133 antibody and its preparation method |
| 04/09/2013 | US8414867 Dry powder formulations |
| 04/09/2013 | US8414857 Calcium phosphate granules of the hydroxyapatite type, their preparation process and their applications |
| 04/09/2013 | US8414657 Method for subcutaneous or intradermal injection |
| 04/09/2013 | US8414563 Pump assembly with switch |
| 04/09/2013 | US8414522 Fluid delivery systems and methods |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2695605C Pyrazolone derivative emulsion formulations |
| 04/09/2013 | CA2694277C Stable formulations of thiadiazole derivatiive |
| 04/09/2013 | CA2651604C Method for preparation of substantially amorphous telmisartan |
| 04/09/2013 | CA2611147C Topical emulsion formulation |
| 04/09/2013 | CA2601501C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 04/09/2013 | CA2457030C Devices including protein matrix materials and methods of making and using same |
| 04/09/2013 | CA2399219C Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 04/04/2013 | WO2013049593A1 Authenticatable coatings for pharmaceutical tablets and ingestible materials |
| 04/04/2013 | WO2013049539A1 A method of blocking or trapping allergens |
| 04/04/2013 | WO2013049538A1 Allergen nasal compositions |
| 04/04/2013 | WO2013049496A1 Biodegradable putty compositions and implant devices, methods, and kits relating to the same |
| 04/04/2013 | WO2013049405A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
| 04/04/2013 | WO2013049380A1 Transdermal patch disposal system |
| 04/04/2013 | WO2013049328A1 Di-aliphatic substituted pegylated lipids |
| 04/04/2013 | WO2013049106A2 Reduction of implant infection via tunable stimulation of localized adaptive immune response |
| 04/04/2013 | WO2013049068A1 Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrom-bogenic agent |
| 04/04/2013 | WO2013048919A1 Cosmetic compositions comprising latex film formers |
| 04/04/2013 | WO2013048734A1 Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes |
| 04/04/2013 | WO2013048453A1 Compounded transdermal pain management |
| 04/04/2013 | WO2013048313A1 Improved formulations of recombinant human bile salt-stimulated lipase |
| 04/04/2013 | WO2013047923A1 Nanoemulsion containing a polyaspartic acid derivative and personal care composition containing same |
| 04/04/2013 | WO2013047915A1 Hybrid powder of halloysite nanotube-light scattering nanoparticles, preparation method thereof, and uv screening cosmetic composition containing same as active ingredient |
| 04/04/2013 | WO2013047869A1 Pharmaceutical composition containing loxoprofen or salt thereof |
| 04/04/2013 | WO2013047802A1 Cooling sheet for attaching to clothing |
| 04/04/2013 | WO2013047795A1 Granular pharmaceutical composition |
| 04/04/2013 | WO2013047568A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | WO2013047567A1 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient |
| 04/04/2013 | WO2013047410A1 Long-acting adhesive skin patch for treating alzheimer's disease, and method for producing same |
| 04/04/2013 | WO2013047376A1 Seamless capsule and manufacturing method therefor |
| 04/04/2013 | WO2013047373A1 Aqueous formulation containing chlorite |
| 04/04/2013 | WO2013047353A1 Orally disintegrating tablet containing hydroxyalkyl cellulose fine particles |
| 04/04/2013 | WO2013047263A1 Hemoglobin-containing liposome and method for producing same |
| 04/04/2013 | WO2013046478A1 Granule and coated granulate |
| 04/04/2013 | WO2013046453A1 Easy-to-take solid preparation |
| 04/04/2013 | WO2013046335A1 Non-aqueous patch |
| 04/04/2013 | WO2013046219A1 Pharmaceutical composition comprising lecithin and process for preparing thereof |
| 04/04/2013 | WO2013046163A1 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents |
| 04/04/2013 | WO2013046161A1 Topical pharmaceutical compositions comprising acyclovir |
| 04/04/2013 | WO2013046133A1 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide |
| 04/04/2013 | WO2013046057A1 Multilayer implants for delivery of therapeutic agents |
| 04/04/2013 | WO2013045961A1 Coating composition |
| 04/04/2013 | WO2013045566A1 N-acetylcysteine effervescent tablet and its therapeutical applications |
| 04/04/2013 | WO2013045538A1 Pharmaceutical preparation for treating nadh-caused diseases |
| 04/04/2013 | WO2013045504A1 Perfluorinated nanoemulsions, method for preparing same, and use thereof as a contrast agent |
| 04/04/2013 | WO2013045455A1 Spray system for production of a matrix formed in situ |
| 04/04/2013 | WO2013045420A1 Plaster having adjustable occlusion |
| 04/04/2013 | WO2013045365A1 Formulations based on solid dispersions |
| 04/04/2013 | WO2013045352A1 Method for producing solid pigment-containing film coating agents in the form of granular materials on the basis of film formers that are resistant to gastric juice for pharmaceutical dosage forms |
| 04/04/2013 | WO2013045333A1 Nanoemulsions and use thereof as contrast agents |
| 04/04/2013 | WO2013045031A1 Composition to be applied to the skin, and use thereof |
| 04/04/2013 | WO2013044871A1 The use of chloroquine, chlorpromazine, derivatives thereof, or mixtures thereof in preparing medications for treating and/or preventing pulmonary infection and injury |
| 04/04/2013 | WO2013044789A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044788A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044734A1 Bone targeted liposome and preparation method therefor |
| 04/04/2013 | WO2013044511A1 Pharmaceutical composition containing riligustilide and use thereof |
| 04/04/2013 | WO2013044341A1 Nanoparticulate magnetic material for thermal applications |
| 04/04/2013 | WO2013021199A3 Eutectic mixture for pulmonary administration |
| 04/04/2013 | WO2013018091A8 Particles for the treatment of neurodegenerative diseases |
| 04/04/2013 | WO2013017910A8 Extended release pharmaceutical compositions containing paliperidone |
| 04/04/2013 | WO2013015634A3 Pharmaceutical composition for treating atopic dermatitis |
| 04/04/2013 | WO2012174555A3 Composition and method for stabilization and delivery of therapeutic molecules |
| 04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
| 04/04/2013 | WO2012042371A3 Pharmaceutical composition |
| 04/04/2013 | WO2011068872A8 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 04/04/2013 | WO2010129309A3 Microencapsulated compositions and methods for tissue mineralization |
| 04/04/2013 | US20130085435 System and method for treating leg ulcers |
| 04/04/2013 | US20130085259 Method and carrier complexes for delivering molecules to cells |
| 04/04/2013 | US20130085182 Sodium 2-mercaptoethane sulfonate for use in the treatment of lumbar pain |
| 04/04/2013 | US20130085165 Buccal Drug Delivery |
| 04/04/2013 | US20130084340 Compositions and Methods of Making Sustained Release Liquid Formulations |
| 04/04/2013 | US20130084339 Composition comprising aluminum silicates and silver nanoparticles as bactericides |
| 04/04/2013 | US20130084338 Method For Producing Solid Pigment-Containing Film Coating Compositions In The Form Of Granules Based On Enteric Film Formers For Pharmaceutical Dosage Forms |
| 04/04/2013 | US20130084336 Enhanced nitric oxide delivery and uses thereof |
| 04/04/2013 | US20130084335 Ivabradine-containing pharmaceutical composition |
| 04/04/2013 | US20130084333 Abuse resistant oral dosage forms |
| 04/04/2013 | US20130084332 Taste masked pharmaceutical composition |
| 04/04/2013 | US20130084330 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient |
| 04/04/2013 | US20130084329 Compositions for external application, containing adenosylcobalamin for improvement of skin diseases |
| 04/04/2013 | US20130084326 Liposomes for the oral delivery of therapeutic agents |
| 04/04/2013 | US20130084325 Manufacturing method of patch preparation |
| 04/04/2013 | US20130084324 Adhesion prevention fabric |
| 04/04/2013 | US20130084323 Fenestrated hemostatic patch |
| 04/04/2013 | US20130084316 Array with fine protrusions |
| 04/04/2013 | US20130084314 Expandable Placental Membrane and Methods of Making and Storing Same |